baber/WOPTO huggingface dataset:
Patent JP-2000509774-A (JP)
Title: 持ち上げヘルド
IPC: D03C7/02
Filed: 1998-01-29
Abstract: (57)【要約】
２つの持ち上げヘルド、及び持ち上げヘルドによりそれぞれ交互に連行される半ヘルドを含み、その際、持ち上げヘルドが、半ヘルドを制御するために一方の端部の範囲に少なくとも１つの磁石を有し、かつ半ヘルドを連行するために橋絡片を有し、その際、橋絡片と磁石との間の間隔が、ほぼ半ヘルドの脚の長さに相当し、かつ持ち上げヘルド（２，３）が、半ヘルド（５０）を磁気的に制動する手段を有する、織物又は編物においてより縁を形成する装置のための持ち上げヘルド。
Patent JP-2001514755-A (JP)
Title: 分光光度分析用キュベット
IPC: G01N21/03
Filed: 1998-03-11
Abstract: (57)【要約】
本発明は、分光光度分析に使用するためのキュベット（４）に関し、電磁エネルギーがその中に含まれた液体サンプル（８）を通過する。本発明の目的は、キュベット（４）の材料と無関係に電磁エネルギーをキュベット（４）及び液体サンプル（８）に通過させることにある。これは、電磁エネルギーを通過させるように整列された開口部（１４，１６；２２，２４）を備えたキュベット（４）を提供することによりなされる。キュベット（４）内に含まれた液体サンプル（８）と接触する前記または各側部（１２；１８，２０）における開口部（１４；２２，２４）は、液体サンプル（８）をその表面張力によりキュベット（４）内に保つように適合される。
Patent JP-2000511372-A (JP)
Title: ビデオ信号センサ
IPC: H04H1/00
Filed: 1997-04-24
Abstract: (57)【要約】
受信機のＣＲＴから修正されたベースバンドビデオ信号を取得するための装置が、受信機のハウジングの外面上にＣＲＴのソケットに隣接して配置された１つの容量ピックアップと、事実上互いに直交している軸を有し、ハウジングの外面上に容量ピックアップから距離を置いて配置された２つの誘導ピックアップとを含んでいる。容量ピックアップは受信機のビデオ信号を検出し、誘導ピックアップは受信機の水平及び垂直同期信号を検出する。ビデオ信号の水平同期要素は、誘導ピックアップによって検出された水平同期信号に応答して置換される。フィルタは、電力線周波数の整倍数辺りを中心とする周波数帯域を濾過して除去するように調整されている。容量ピックアップは、容量ピックアッププレートと、容量ピックアッププレートよりもソケットから遠くに配置されている容量シールドプレートとを有している。２つの誘導ピックアップのうちの１つの軸が、ＣＲＴの軸に平行である。
Patent JP-2002501602-A (JP)
Title: 耐凍性回転流体管理装置
IPC: F04D1/12
Filed: 1998-03-13
Abstract: (57)【要約】
回転流体管理装置（ＲＦＭＤ）（１０）と、ＲＦＭＤ（１０）に接続されて、システムが作動していない時にシステム内の作動流体をＲＦＭＤ（１０）に排水できるように構成された流体流れループ（２２）とを含む流体システムに、凍結しやすい作動流体を使用できるようにする。ＲＦＭＤ（１０）は、入口ポート（６０，６４）、第１出口ポート（５６）および第２出口ポート（６２）を有するハウジング（３２）と、垂直軸線（３８）回りに回転可能にハウジング（３２）に取り付けられたタンク（３４）と、作動流体を入口ポート（６０、６４）からタンク（３４）に送る戻し部（９２、９３）と、ハウジング（３２）に固定されてタンク（３４）内の半径方向外側位置（１１８）まで延出して、液相の作動流体をタンクから第１出口ポート（６２）に送るピトー管（１１６）と、半径方向外側位置（１１８）より半径方向内側に位置して、気相作動流体をタンク（３４）から第２出口ポート（５６）に送るベント（１２１）とを備えている。タンク（３４）は、システムが作動していない時にシステム内のすべての作動流体を貯留できる大きさの貯留容積部分（８４）を有している。貯留容積部分（８４）は、垂直軸線（３８）上に中心が位置する上向きに開放した凹状の回転表面（８６）によって形成されている。
Patent JP-2001522357-A (JP)
Title: 炎症性疾患の治療に有用な置換イミダゾール
IPC: A61P19/10
Filed: 1998-04-17
Abstract: (57)【要約】
 本発明は、一連の式Ｉの置換イミダゾール類、それらを含有する医薬組成物およびそれらの製造において使用される中間体に関する。本発明の化合物は、多数の炎症性サイトカインの産生を抑制し、そして炎症性サイトカインの過剰産生に関連する疾病の治療において有用である。
Patent JP-2001522305-A (JP)
Title: 酸性石灰スケール除去組成物
IPC: C11D3/02
Filed: 1998-04-24
Abstract: (57)【要約】
本発明は、直径４ｃｍの円錐スピンドルを用いて、２０℃で、５Ｎ／ｍ 2 で、Carri-medレオメーターを用いて測定した場合に、少なくとも１０ｍＰａｓの粘度を有し、かつ４より低いｐＨの液体酸性増粘化組成物であって、両イオン性界面活性剤対陰イオン性界面活性剤の重量比が少なくとも２：１の両イオン性界面活性剤および陰イオン性界面活性剤、ならびに総組成物の０．１〜７０重量％の酸を包含する自己増粘系を含む組成物に関する。この組成物は、優れた石灰スケール除去作用を示し、硬質表面上の油脂性石鹸浮滓の清浄作用もある。この組成物は水平面、非水平面の清浄化に適している。
Patent JP-2001524973-A (JP)
IPC: C07F9/38
Filed: 1998-04-14
Abstract: Styrene phosphonic acid (SPA) can be formed the reaction of phosphorous acid with acetophenone, preferably in the presence of a Lewis acid catalyst, to form a hydroxy adduct intermediate thereof which is then reacted with acetic anhydride to form the acyl derivative of the hydroxy adduct, followed by removal of an acetic acid moiety therefrom, preferably in the presence of an acidic catalyst, to form the styrene phosphonic acid product.
Patent JP-2001524202-A (JP)
Title: セパレーターを有する吸着冷蔵庫
IPC: H01M8/04
Filed: 1998-05-08
Abstract: (57)【要約】
冷却効果を発生させるための吸着剤(10)を使用する伝熱装置(２)。伝熱装置(２)は、吸着剤(10)を含む第一容器(４)、および第一容器(４)に相互連絡している第二容器(６)を包含する。２個の相互連絡した容器(４、６)内には、作用物質が含まれている。この作用物質は、第二容器(６)から第一容器(４)の方へと蒸気として引き出されて、第二容器(６)を冷却する。セパレータ装置(430)は、第二容器(６)から第一容器(４)の方へと通る蒸気の少なくとも一部を分離して、第一容器(４)中の吸着剤(10)が蒸気で飽和される時点を遅らせる。吸着剤(10)は、炭素繊維(613、910)を包含でき、これは、そこに電流を通したとき、この作用物質を脱離する。炭素繊維(613)はまた、コンテナ(600)内にも配置でき、この炭素繊維が脱離したとき、コンテナ(600)中の流体を移動させる。
Patent MD-20000044-A (MD)
Title: Process for broadcasting the advertising information
Inventor: KOKHAN IRINA
IPC: G09F9/00
Filed: 2000-03-02
Abstract: The invention relates to the field of broadcasting the audio and/or video advertising information.The process for broadcasting the advertising information includes audio and/or video broadcasting light spots and the publicity broadcast is carried out on the passenger transport, where the broadcast source is installed immediately on the transport and is provided with variable supporting media of the advertising information.
Patent MD-20050151-A (MD)
Inventor: BEAUCHET FRUDURIC
IPC: G07D7/20
Filed: 2005-05-26
Abstract: Foaia de material fibros (1) contine inclus in eaun segment de pelicula (2), care contine perforatii (8, 10) cu inaltimi diferite repartizate pe o parte a segmentului de pelicula astfel, incat partea perforata sa aiba porozitate omogena, totodata fibrele sunt introduse in perforatii (8, 10).
Patent MX-158259-A (MX)
Inventor: MITCHELL HAL D
IPC: F16F7/00
Filed: 1981-09-04
Abstract: A shock attenuation system for headgear having an outer protective shell, the system comprising a liner adapted to be secured to the internal surface of the shell, the liner comprising a series of tubes of elastomeric material extending with their axes generally parallel to the internal surface of the shell, and generally parallel to one another. Each tube is open at an end thereof and is elastically deformable under loads applied against the side of the tube, whereby, with the headgear worn by a wearer and upon application of an impact load to the headgear, the tubes in the area of impact deform elastically under the applied load and attenuate the shock upon the wearer from the applied load.
Patent NZ-197714-A (NZ)
Title: Substituted pyrimidin-2-ones and pharmaceutical compositions
Inventor: PHILLIPPS G H
IPC: C07D405/06
Filed: 1981-07-14
Abstract: Compounds of the general formula:   <IMAGE> I  (wherein X represents a halogen atom or a trifluoromethyl group; R1 represents an optionally substituted C6-10 carbocyclic aromatic group; and R2 represents a hydrogen atom or a lower alkyl, C7-16 aralkyl or C6-10 aryl group or the group COR1a, in which R1a is as defined for R1, R1 and R1a being the same or different) and where an acidic or basic group is present, the salts thereof have been found to possess excellent metaphase arresting ability and are of use in combating abnormal cell proliferation. Thus a knowledge of the cell division cycles of the normal and abnormal cells enables a cytotoxic drug to be administered while the abnormal cells are in a phase susceptible to attack and while the normal cells are in a non-susceptible phase. The compounds of the invention are prepared by alkylation, deprotection of a protected keto group, oxidation or electrophilic halogenation. Pharmaceutical compositions containing the compounds of formula I, and where appropriate, the physiologically compatible salts thereof; and methods for the use of the compounds are described and claimed.
Patent NZ-212513-A (NZ)
Title: Synergistic composition containing an interferon and tissue necrosis factor
Inventor: ADOLF GUENTHER
IPC: A61K38/16
Filed: 1985-06-21
Abstract: Ternary compositions of an interferon of the alpha and/or beta type with an interferon of the gamma type and tumor necrosis factor having a surprising and unexpected synergistic anti-proliferative effect on neoplastic cells when compared to the activity of the individual components of this invention, said compositions being useful in the treatment of neoplasia in animals including humans.
Patent NZ-214711-A (NZ)
Title: Recombinant dna molecule coding for tumour necrosis factor
Inventor: FIERS WALTER C
IPC: C12P21/02
Filed: 1985-12-23
Abstract: A process for purifying mammalian TNF from a composition comprising the steps of (a) precipitating crude TNF from the composition; (b) fractionating TNF by anion exchange chromatography at a mild alkaline pH; (c) fractioning TNF by gel filtration; and (d) fractionating TNF by anion exchange chromatography at a slightly acidic pH.
Patent NZ-240121-A (NZ)
Title: Double-action spray pump: forced air travels down hollow piston shaft
Inventor: DEMAREST SCOTT W
IPC: B05B7/24
Filed: 1991-10-07
Abstract: A manually operable spray pump with a double-action pump and a detachable fluid reservoir. A pump cylinder has valves at each end to admit air into one of two pump chambers formed by a piston and means to simultaneously force air from the other chamber down a shaft and out over a fluid discharge port, thereby pulling fluid from the reservoir and spraying it from the device.
Patent NZ-248210-A (NZ)
Title: Use of heterocyclically-substituted benzothiophene derivatives in preparing medicaments for treating osteoporosis and inhibiting bone loss
Inventor: BLACK LARRY JOHN
IPC: A61K31/425
Filed: 1993-07-21
Abstract: The use of raloxifene, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for preventing or treating osteoporosis in a postmenopausal woman.
Patent NZ-261373-A (NZ)
Title: Limb protector: pivoting upper and lower curved supports
Inventor: DOYLE KELVIN CONRAD
IPC: A61F5/01
Filed: 1994-02-16
Abstract: A limb protector to protect a knee or elbow joint in active sports and also for use after the joint has been injured has upper and lower curved, rigid, resilient supports which can be attached to an arm or leg above and below the knee or elbow, is arranged so that the upper and lower supports can rotate relative to each other, by an adjustable amount, in a horizontal plane and can also hinge relative to each other in a vertical plane.
Patent NZ-290374-A (NZ)
Title: Process for the renaturation of monomeric, denatured tgf-beta-like protein
Inventor: CERLETTI NICO
IPC: C07K14/495
Filed: 1995-07-12
Abstract: The present invention relates to a folding process for the preparation of biologically active, dimeric, TGF-beta (Transforming Growth Factor type beta)-like protein in a detergent-free folding buffer.
Patent NZ-292369-A (NZ)
Title: Protein and coding sequence for ciita transcription activation domain and methods for identifying compounds inhibiting it and this inhibiting mhc class ii gene expression
Inventor: GLIMCHER LAURIE H
IPC: C12Q1/68
Filed: 1995-08-22
Abstract: Disclosed are methods of identifying compounds which inhibit transcription activation by CIITA and thus inhibit MHC class II gene expression. Such compounds can affect the induction of an immune response. The methods employ, independently, the activation and interactions domains of CIITA. The methods also employ the activation and interaction domains of isotype-specific CIITA proteins, allowing for the identification of compounds which are isotype-specific inhibitors of transcription and which are useful for selectively affecting the immune system.
Patent NZ-308016-A (NZ)
Title: use of a carbonic anhydrase inhibitor applied topically to increase retinal blood flow
Inventor: HARRIS ALON
IPC: A61K45/00
Filed: 1996-05-17
Abstract: A carbonic anhydrase inhibitor and an ophthalmologically acceptable carrier are used in the manufacture of a medicament for topical application to the eye for maximizing the health of the optical nerve and retina, for increasing retinal blood flow velocity and for increasing optic nerve head velocity. The carbonic anhydrase inhibitor can be dorzolamide, acetazolamide or metazolamide.
Patent NZ-319746-A (NZ)
Title: A synergisitic combination of a beta-receptor blocker and an opioid
Inventor: EEK ARNE
IPC: A61K45/08
Filed: 1996-10-03
Abstract: The synergistic combination of a b-receptor blocker or a pharmaceutically acceptable salt thereof and opioid or a pharmaceutically acceptable salt thereof is claimed.  The combination is useful in the management of pain.
Patent NZ-329642-A (NZ)
Title: N-dodecyl substituted heterocyclic compound for inhibiting microorganism growth in aqueous system
Inventor: HOLLIS GEORGE C
IPC: A01N33/04
Filed: 1993-05-14
Abstract: A method for inhibiting the growth of at least one micro-organism in a susceptible industrial aqueous system, comprising the step of contacting said industrial aqueous system with an N-dodecyl heterocyclic compound as detailed in Formula 1. In Formula 1: The heterocyclic ring is an optionally substituted group selected from pyrrolidinyl, 2-pyrrolidinonyl, pyrrollinyl, pyrazolidinyl, pyrazolinyl, pyrazolyl, imidizolidinyl, imidizolinyl, imidazolyl, oxazolinyl, piperadinyl, piperazinyl, morpholinyl, hexamethyleneimine or heptamethyleneimine, in an amount effective to inhibit the growth of said organism
Patent NZ-330138-A (NZ)
Title: Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
Inventor: CLEMENT BERND
IPC: A01N43/42
Filed: 1996-10-11
Abstract: PCT No. PCT/DE96/01958 Sec. 371 Date Apr. 13, 1998 Sec. 102(e) Date Apr. 13, 1998 PCT Filed Oct. 11, 1996 PCT Pub. No. WO97/14683 PCT Pub. Date Apr. 24, 1997The invention relates to phenanthridine derivatives of the general formula I and II and also its salts, in which R1 means a hydrogen atom, an aromatic, carbocyclic or hetercyclic or heterocyclic residue and in which R2 and R3, which can be the same or different, mean a hydrogen atom, an alkyloxy residue, an alkylenoxy residue, a halogen atom or a nitro group.
Patent NZ-332911-A (NZ)
Title: Toilet cleansing block comprising anionic surfactant, binder and C9-20 alcohol
Inventor: WORTLEY RUSSEL B
IPC: C11D1/14
Filed: 1997-05-14
Abstract: A toilet cleansing block comprising: a) 30-70% by weight of anionic surfactant b) up to 3% by weight of a binder selected from cellulose binder and gum c) 3-10% by weight of linear primary alcohol, wherein the alcohol has 9-20 carbon atoms and the weight ration of the alcohol to the surfactant is between 1:3 and 1:20; wherein the time for the block to completely dissolve in the "In tank test in water of zero hardness as expressed in terms of calcium carbonate and at a temperature of 18-20oC would be at least 70% of the time for the block to completely dissolve in the test in water containing between 115-130ppm hardness expressed in terms of calcium carbonate and at a temperature of 13-14oC wherein neither such test would the block completely dissolve prior to 150 flushes.
Patent NZ-333708-A (NZ)
Title: Preparation of polyol fatty acid polyesters from sucrose and fatty acid alkyl esters using atmospheric or superatmospheric pressure
Inventor: SCHAFERMEYER RICHARD GERARD
IPC: C07C67/02
Filed: 1997-07-16
Abstract: The method for the solvent-less transesterification of sucrose comprises reacting sucrose with fatty acid alkyl ester in the presence of a basic catalyst to produce sucrose fatty acid polyester products and alkyl alcohol by-products.  The majority of the sucrose is converted to octa-ester and the reaction is conducted in a reactor at a temperature in the range of from 60oC to 180oC at atmospheric or superatmospheric pressure.  The reaction involves sparging an inert gas through the reactor with sufficient mass transfer surface area contact between the inert gas and a liquid mixture of reactant and product to transfer the alkyl alcohol by-product from the liquid mixture to the inert gas and promote conversion of a majority of the sucrose to octa-ester without the use of vacuum pressure.
Patent NZ-334940-A (NZ)
Title: process of producing 4-(des-dimethylamino)-tetracycline
Inventor: HEGGIE WILLIAM
IPC: C25B3/25
Filed: 1999-03-30
Abstract: The process comprises electrochemically reducing a trialkylammonium salt of a tetracycline in an aqueous solution having an acid pH and containing an electrolyte.
Patent NZ-337969-A (NZ)
Title: use of a pulmonary alveolar surfactant for treating sleep apnea
Inventor: MEYER KEITH C
IPC: A61K35/42
Filed: 1998-04-16
Abstract: A pulmonary alveolar surfactant such as a phospholipid containing surfactant is used to treat sleep apnea and is applied to the posterior pharyngeal region of the patient prior to a period of sleep.
Patent NZ-500914-A (NZ)
Title: Cross over coupling variation of circulator strip conductors
Inventor: SCHUCHINSKY ALEXANDER GRIGORIE
IPC: H01P1/387
Filed: 1998-05-19
Abstract: The crossing branches (strip conductors) of conductors 11, 12, 13 of a lumped element circulator may be tapered (as shown), have notches or protuberances or directional deviations, or be curved to vary the local width of the strip conductors between crossovers to provide substantially different amounts of coupling between the strip conductors at selected individual crossovers.  This provides different lumped couplings and alters the ratio between capacitive and inductive couplings at selected crossovers.
Patent NZ-506513-A (NZ)
Title: Modular vacuum drainage system
Inventor: PONDELICK MARK
IPC: C02F1/00
Filed: 2000-08-23
Abstract: A modular vacuum central (10) for use with vacuum drainage piping comprises a frame (14) and a tank (28,30) mounted on frame (14).  The tank has a fluid intake connection (32,38) adapted for fluid communication with the vacuum drainage piping (8).  The vacuum central has a vacuum inlet (34,42), a vent inlet (60), and a drain outlet (46).  A vacuum generator (50,51) is mounted on frame (14).  The vacuum generator (50) has an inlet (52) in fluid communication with the vacuum inlet (34,42) to create a vacuum in tank (28,30), and an exhaust outlet (66).  A control panel (70) is attached to frame (14) and is operatively connected to vacuum generator (50,51).  The control panel has a power connection (72).  An enclosure (12) is attached to frame (14) and surrounds tank (28,30) and vacuum generator (50,51).  The fluid intake connection (32), vent inlet (60), drain outlet (46), exhaust outlet(66), and power connection (72) are located adjacent to a periphery of enclosure (12).
Patent NZ-509964-A (NZ)
Title: Methods for using resonant acoustic and/or resonant acousto-EM energy to detect and/or effect structures
Inventor: BROOKS JULIANA H J
IPC: A61B5/05
Filed: 1999-09-10
Abstract: Resonant acoustic and/or acousto-EM energy is applied to inorganic or biologic structures for the detection and/or identification, and for augmentation and/or disruption of function within the biologic structure. A method of generating resonant acoustic and/or acousto-EM energy in biologic structures such as virus, bacteria, fungi, worms and tumors for the detection and disruption of these structures is described. Also described is a method of augmenting functions of biologic structures such as bone through the generation of resonant acoustic and/or acousto-EM energy in the structure. Systems are also provided for the generation and detection of resonant acoustic and/or resonant acousto-EM energy.
Patent NZ-511034-A (NZ)
Title: Methods of downmodulating the immune response to therapeutic proteins
Inventor: QIAN JIAHUA
IPC: A61K45/06
Filed: 1999-09-21
Abstract: A composition comprising a therapeutic protein, such as factor VIII, which promotes hemostasis and an agent, such as CTLA4, which inhibits the interaction of a costimulatory molecule on an antigen presenting cell and its cognate ligand on a T cell, wherein said composition is a composition for the treatment of a hemostatic disorder which reduces the development and/or progression of an immune response to the therapeutic protein.
Patent NZ-512945-A (NZ)
Title: Antifouling paint
Inventor: FOX JOHN
IPC: C09D193/04
Filed: 2000-01-18
Abstract: An antifouling paint having a binder comprising a rosin material and an auxiliary film-forming resin, the paint including an ingredient having marine biocide properties, wherein the binder comprises a blend of the rosin material and an auxiliary film-forming resin in a ratio of 20:80 to 95:5 by weight, the auxiliary film-forming resin comprising 20-100% by weight of an acid-functional film-forming polymer (A) whose acid groups are blocked by groups capable of hydrolyzing or dissociating to leave a polymer soluble in sea water, the blocking groups being selected from divalent metal atoms bonded to a monovalent organic residue, divalent metal atoms bonded to a hydroxyl residue and monoamine groups which form an organic solvent soluble amine salt of the polymer, and 80-0% by weight of a non-hydrolyzing water-insoluble film-forming polymer (B).
Patent NZ-514717-A (NZ)
Title: Bumper mounted spare wheel carrier with raising and lowering actuator
Inventor: NEWBILL ANTHONY J
IPC: B60R9/06
Filed: 2001-10-10
Abstract: A spare wheel can be bolted to the bracket 16 of a carrier that is bolted at mounting bracket 5 to the back bumper of a utility vehicle.   When the latch pin 9 is released, the arm 7 can be swung on the axis of bolt 8 to move the arm away from the rear of the vehicle and off the rest 20, then the ratchet handle 22 can be operated to open the turnbuckle screw 25 to lower the arm and attached wheel about pivot bolt 15 toward the ground.  A wheel can be bolted to the bracket 16 and raised and locked into position adjacent the rear door of the vehicle by actuation of the ratchet in the opposite direction.  The manual power ratchet may be replaced by a motor powered mechanism energized from the vehicle electrical power source.
Patent NZ-517541-A (NZ)
Title: Pharmaceutical preparation containing nanosol
Inventor: HOFFMANN HANS-RAINER
IPC: A61K9/51
Filed: 2000-08-14
Abstract: A solid pharmaceutical preparation comprises at least one at least partially charged active substance. The active substance is in the form of a nanosol in which the active substance is bonded to an oppositely charged chitosan derivative. The preparation can be used in the production of a medicinal product. The pharmaceutical preparation is produced by selecting a chitosan derivative according to the type and relative number of its charged group and in coordination with the type and relative number of the charged groups of the active substance, such that at a certain pH value an isoionic state or charge equalization between active substance and carrier can achieved in the preparation.  An aqueous sol containing the active substance is prepared from the chitosan derivative. The pH of the aqueous sol is adjusted and then the aqueous sol is dried.
Patent NZ-521633-A (NZ)
Title: Use of an adenosine A2 or A2b recpetor antagonist for promoting bowel movement
Inventor: YASUDA MASAHIRO
IPC: A61K31/522
Filed: 2001-04-26
Abstract: Drugs having a gentle and potent effect of promoting the bowel movement without causing diarrhea are disclosed. Namely, bowel movement promoters which contain compounds having an adenosine A2 receptor antagonism (preferably compounds having an adenosine A2b receptor antagonism) or salts thereof are disclosed.
Patent NZ-521657-A (NZ)
Title: Free-flowing simethicone compositon for forming a solid oral dosage form
Inventor: SZYMCZAK CHRISTOPHER E
IPC: A61K9/14
Filed: 2002-09-27
Abstract: A composition for forming a compressed solid dosage form comprising a free-flowing compressible admixture of simethicone and an adsorbent, wherein the weight ratio of simethicone to adsorbent is at least about 1:2.00. The composition may also include an active ingredient such as bisacodyl, famotidine, diphenoylate, loperamide and mesalamine.
Patent NZ-522335-A (NZ)
Title: Preparation of injectable suspensions having improved injectability
Inventor: RAMSTACK J MICHAEL
IPC: A61K9/00
Filed: 2001-04-19
Abstract: Injectable compositions having improved injectability are described. The injectable compositions include microparticles suspended in an aqueous injection vehicle having a viscosity of greater than 60 cp and less than 600 cp at 20C. The injectable compositions can be made by mixing dry microparticles with an aqueous injection vehicle to form a suspension, and then mixing the suspension with a viscosity enhancing agent to increase the viscosity of the fluid phase of the suspension to the desired level for improved injectability
Patent NZ-523014-A (NZ)
Title: Perforating drill with spiral evacuation grooves
Inventor: DEFOUGERES FRANCOIS
IPC: B23B51/02
Filed: 2001-04-26
Abstract: The drill bit comprises a cylindrical body (2) tipped with a head (3) with a carbide insert (4) and provided over part of its length with spiral evacuating grooves (5). The grooves are delimited over part of their length by a succession of facets (7) joined to one another by sharp edges or by blending radii (8).
Patent NZ-524404-A (NZ)
Title: Indole derivatives and their use as medicaments
Inventor: EMIG PETER
IPC: A61P35/00
Filed: 2001-07-26
Abstract: Indole derivatives of formula (I) that are suitable as medicaments for treating tumours, and the process for the production of these derivatives is disclosed, wherein the variables are as defined in the specification.